Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Chronic Kidney Disease, Metabolic Syndrome, and Cardiovascular Risk: Insights and Associated Mechanistic Pathways

Author(s): Thaís Rodrigues Nogueira*, Camila Santos Marreiros and Betânia de Jesus e Silva de Almendra Freitas

Volume 18, Issue 6, 2022

Published on: 13 April, 2022

Page: [539 - 548] Pages: 10

DOI: 10.2174/1573401318666220203164619

Price: $65

Abstract

This study is a narrative review that aims to address the conceptual, characteristic, pathophysiological, and mechanistic aspects that define the profile of metabolic syndrome and chronic kidney disease. The objective was to investigate current knowledge and elucidate, through discussions on the topic, the main interrelated paths. This review was carried out unsystematically, from March to May 2020, by means of a survey of the literature indexed in the PubMed, Web of Science, and Scopus (Elsevier®) databases. The scientific materials collected showed that the cross-talk between the diseases in question is mainly based on the conditions of resistance to insulin action, endothelial dysfunction, activation pathways of the Renin- Angiotensin-Aldosterone System, and adipokine imbalance, also emphasizing the influence of atherosclerotic events in kidney damage. Furthermore, it was reinforced that inflammatory processes play an important role in the worsening and evolution of the clinical condition of patients, especially when they have underlying pathologies chronically treated for subclinical inflammation. It is expected that more original research will propose investigating other possible interactions with a view to standardized treatment of these diseases or nutritional management.

Keywords: Review literature, nephropathy, metabolic syndrome, hemodialysis, inflammation, Chronic Kidney Disease (CKD).

« Previous Next »
Graphical Abstract

[1]
Brazilian society of nephrology. sbn dialysis census 2019. Available from: https://sbn. org.br/censo-de-dialise-sbn-2018/
[2]
Thomé FS, Sesso RC, Lopes AA, Lugon JR, Martins CT. Brazilian chronic dialysis survey 2017. J Bras Nefrol 2019; 41(2): 208-14.
[http://dx.doi.org/10.1590/2175-8239-jbn-2018-0178] [PMID: 30968930]
[3]
Bastos MG, Bregman R, Kirsztajn GM. Chronic kidney diseases: Common and harmful, but also preventable and treatable. Rev Assoc Med Bras 2010; 56(2): 248-53.
[http://dx.doi.org/10.1590/S0104-42302010000200028] [PMID: 20499004]
[4]
Ito S, Yoshida M. Protein-bound uremic toxins: New culprits of cardiovascular events in chronic kidney disease patients. Toxins (Basel) 2014; 6(2): 665-78.
[http://dx.doi.org/10.3390/toxins6020665] [PMID: 24561478]
[5]
Matsushita K, van der Velde M, Astor BC, et al. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375(9731): 2073-81.
[http://dx.doi.org/10.1016/S0140-6736(10)60674-5] [PMID: 20483451]
[6]
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet 2013; 382(9889): 339-52.
[http://dx.doi.org/10.1016/S0140-6736(13)60595-4] [PMID: 23727170]
[7]
Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009; 53(23): 2129-40.
[http://dx.doi.org/10.1016/j.jacc.2009.02.047] [PMID: 19497438]
[8]
Silva ACC Jr, Abensur H, Lotaif LD, Amodeo C, Piegas LP. New cardiovascular risk factors. Rev Soc Cardiol State of São Paulo 2007; 17(1): 50-9.
[9]
Soulage CO, Koppe L, Fouque D. Protein-bound uremic toxins…new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease. J Ren Nutr 2013; 23(6): 464-6.
[http://dx.doi.org/10.1053/j.jrn.2013.06.003] [PMID: 23938300]
[10]
Bäckhed F. Meat-metabolizing bacteria in atherosclerosis. Nat Med 2013; 19(5): 533-4.
[http://dx.doi.org/10.1038/nm.3178] [PMID: 23652100]
[11]
Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H. Cardiorenal syndrome: The emerging role of protein-bound uremic toxins. Circ Res 2012; 111(11): 1470-83. [Erratum in: Circ Res. 2014;114]. [2]. [:e23].
[http://dx.doi.org/10.1161/CIRCRESAHA.112.278457] [PMID: 23139286]
[12]
Fujii H, Nakai K, Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial 2011; 15(2): 125-8.
[http://dx.doi.org/10.1111/j.1744-9987.2010.00883.x] [PMID: 21426501]
[13]
Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140(3): 167-74.
[http://dx.doi.org/10.7326/0003-4819-140-3-200402030-00007] [PMID: 14757614]
[14]
Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. Eur J Epidemiol 2010; 25(6): 375-84.
[http://dx.doi.org/10.1007/s10654-010-9459-z] [PMID: 20425137]
[15]
Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: The weight of the evidence. Adv Chronic Kidney Dis 2006; 13(4): 365-73.
[http://dx.doi.org/10.1053/j.ackd.2006.07.011] [PMID: 17045222]
[16]
Townsend RR, Anderson AH, Chen J, et al. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol 2011; 33(6): 477-84.
[http://dx.doi.org/10.1159/000327618] [PMID: 21525746]
[17]
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(5)(Suppl. 3): S112-9.
[http://dx.doi.org/10.1053/ajkd.1998.v32.pm9820470] [PMID: 9820470]
[18]
Alswat KA, Althobaiti A, Alsaadi K, et al. Prevalence of metabolic syndrome among the end-stage renal disease patients on hemodialysis. J Clin Med Res 2017; 9(8): 687-94.
[http://dx.doi.org/10.14740/jocmr3064w] [PMID: 28725317]
[19]
National Institute for Health and Clinical Excellence Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. London: Royal College of Physicians 2011.
[20]
Cuppari L. Clinical nutrition in adults - Guide to outpatient and hospital medicine (UNIFESP/Escola Paulista de Medicina). 1st ed. São Paulo: Manole 2014.
[21]
Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant 2016; 31(6): 868-74.
[http://dx.doi.org/10.1093/ndt/gfv466] [PMID: 27217391]
[22]
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012; 379(9818): 815-22.
[http://dx.doi.org/10.1016/S0140-6736(12)60033-6] [PMID: 22386035]
[23]
Kim S, Lim CS, Han DC, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: A population-based cross-sectional epidemiologic study. J Korean Med Sci 2009; 24(Suppl. 1): S11-21.
[24]
Ministry of Health National policy of care for patients with kidney disease in the Unified HealthSystem. Federal University of Maranhão UNA -SUS/UFMA - São Luís 2014.
[25]
Braga Flm Renal disease in hypertensive patients with metabolic syndrome 2012.
[26]
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009; 120(16): 1640-5.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644] [PMID: 19805654]
[27]
Kul S, Uyarel H, Gul M, et al. Metabolic syndrome and long-term cardiovascular outcomes in NSTEMI with unstable angina. Nutr Metab Cardiovasc Dis 2014; 24(2): 176-82.
[http://dx.doi.org/10.1016/j.numecd.2013.07.003] [PMID: 24439842]
[28]
Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol 2012; 32(8): 1754-9.
[http://dx.doi.org/10.1161/ATVBAHA.111.241885] [PMID: 22815340]
[29]
Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52(5): 1210-4.
[http://dx.doi.org/10.2337/diabetes.52.5.1210] [PMID: 12716754]
[30]
Lee HS, Lee KB, Hyun YY, Chang Y, Ryu S, Choi Y. DASH dietary pattern and chronic kidney disease in elderly Korean adults. Eur J Clin Nutr 2017; 71(6): 755-61.
[http://dx.doi.org/10.1038/ejcn.2016.240] [PMID: 27966569]
[31]
Song YM, Sung J, Lee K. Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. Clin Exp Nephrol 2015; 19(5): 887-94.
[http://dx.doi.org/10.1007/s10157-015-1083-5] [PMID: 25634252]
[32]
Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002; 13(6): 1626-34.
[http://dx.doi.org/10.1097/01.ASN.0000015762.92814.85] [PMID: 12039992]
[33]
Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 2006; 17(4)(Suppl. 2): S81-5.
[http://dx.doi.org/10.1681/ASN.2005121332] [PMID: 16565254]
[34]
Luk AO, So WY, Ma RC, et al. Hong Kong Diabetes Registry. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008; 31(12): 2357-61.
[http://dx.doi.org/10.2337/dc08-0971] [PMID: 18835954]
[35]
Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993; 22(3): 292-9.
[http://dx.doi.org/10.1161/01.HYP.22.3.292] [PMID: 8349321]
[36]
Briones AM, Nguyen Dinh Cat A, Callera GE, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: Implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012; 59(5): 1069-78.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.190223] [PMID: 22493070]
[37]
Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med (Berl) 2008; 86(6): 729-34.
[http://dx.doi.org/10.1007/s00109-008-0343-1] [PMID: 18437332]
[38]
Kopple JD. Obesity and chronic kidney disease. J Ren Nutr 2010; 20(5)(Suppl.): S29-30.
[http://dx.doi.org/10.1053/j.jrn.2010.05.008] [PMID: 20797567]
[39]
Cushman WC, Ford CE, Cutler JA, et al. ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4(6): 393-404.
[http://dx.doi.org/10.1111/j.1524-6175.2002.02045.x] [PMID: 12461301]
[40]
Armitage JA, Burke SL, Prior LJ, et al. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension 2012; 60(1): 163-71.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.190413] [PMID: 22647890]
[41]
Bonnard C, Durand A, Peyrol S, et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 2008; 118(2): 789-800.
[http://dx.doi.org/10.1172/JCI32601] [PMID: 18188455]
[42]
Takabe W, Li R, Ai L, Yu F, Berliner JA, Hsiai TK. Oxidized low-density lipoprotein-activated c-Jun NH2-terminal kinase regulates manganese superoxide dismutase ubiquitination: implication for mitochondrial redox status and apoptosis. Arterioscler Thromb Vasc Biol 2010; 30(3): 436-41.
[http://dx.doi.org/10.1161/ATVBAHA.109.202135] [PMID: 20139358]
[43]
Danziger J. The bone-renal axis in early chronic kidney disease: An emerging paradigm. Nephrol Dial Transplant 2008; 23(9): 2733-7.
[http://dx.doi.org/10.1093/ndt/gfn260] [PMID: 18469306]
[44]
Davies MR, Lund RJ, Mathew S, Hruska KA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 2005; 16(4): 917-28.
[http://dx.doi.org/10.1681/ASN.2004100835] [PMID: 15743994]
[45]
Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 2010; 141(2): 122-31.
[http://dx.doi.org/10.1016/j.ijcard.2009.09.543] [PMID: 19910061]
[46]
Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: The Atherosclerosis Risk in Communities study, 1987-1998. Circulation 2003; 107(17): 2190-5.
[http://dx.doi.org/10.1161/01.CIR.0000066324.74807.95] [PMID: 12695289]
[47]
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351(9101): 478-84.
[http://dx.doi.org/10.1016/S0140-6736(97)11144-8] [PMID: 9482439]
[48]
Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res 2017; 183: 14-25.
[http://dx.doi.org/10.1016/j.trsl.2016.12.004] [PMID: 28025032]
[49]
Carnelosso ML, Barbosa MA, Porto CC, Silva SA, Carvalho MM, Oliveira ALI. Prevalence of risk factors for cardiovascular diseases in the eastern region of Goiânia (GO). Science Collective Health 2010; 15(Suppl. 1): 1073-80.
[50]
Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: A simulation model for the CDC CKD Initiative. Am J Kidney Dis 2015; 65(3): 403-11.
[http://dx.doi.org/10.1053/j.ajkd.2014.09.023] [PMID: 25468386]
[51]
Ferreira CCC, Peixoto MRG, Barbosa MA, Silveira EA. Prevalence of cardiovascular risk factors in elderly users of the Goiânia Unified Health System. Arq Bras Cardiol 2010; 95(5): 621-8.
[http://dx.doi.org/10.1590/S0066-782X2010005000141] [PMID: 21109910]
[52]
Bakris GL. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc 2011; 86(5): 444-56.
[http://dx.doi.org/10.4065/mcp.2010.0713] [PMID: 21531886]
[53]
Vieira JM, Suassuna JHR. Renal involvement in hypertension and type 2 diabetes mellitus: How to identify prevent? The nephrologist’s vision. HUPE Magazine 2013; 12(Suppl. 1): 53-60.
[54]
Tumlin JA, Costanzo MR, Chawla LS, et al. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 158-73.
[http://dx.doi.org/10.1159/000349972] [PMID: 23689661]
[55]
Bucharles SGE, Varela AM, Barberato SH, Pecoits-Filho R. Assessment and management of cardiovascular disease in patients with chronic kidney disease. J Bras Nefrol 2010; 32(1): 118-25.
[PMID: 21448530]
[56]
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-13.
[http://dx.doi.org/10.1016/S0140-6736(02)11911-8] [PMID: 12493255]
[57]
Bucharles SGE, Wallbach KKS, Moraes TP, Pecoits-Filho R. Hypertension in dialysis patients: Diagnosis, mechanisms and treatment. J Bras Nefrol 2019; 41(3): 400-11.
[http://dx.doi.org/10.1590/2175-8239-jbn-2018-0155] [PMID: 30421784]
[58]
Sarafidis PA, Persu A, Agarwal R, et al. Hypertension in dialysis patients: A consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant 2017; 32(4): 620-40.
[http://dx.doi.org/10.1093/ndt/gfw433] [PMID: 28340239]
[59]
The Third Report of the National Cholesterol Education Program (NECP). Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.
[60]
Amorim RG, Guedes GDS, Vasconcelos SML, Santos JCF. Kidney disease in diabetes mellitus: Cross-linking between hyperglycemia, redox imbalance and inflammation. Arq Bras Cardiol 2019; 112(5): 577-87.
[http://dx.doi.org/10.5935/abc.20190077] [PMID: 31188964]
[61]
Jha JC, Banal C, Chow BSM, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: Role of oxidative stress. Antioxid Redox Signal 2016; 25(12): 657-84.
[http://dx.doi.org/10.1089/ars.2016.6664] [PMID: 26906673]
[62]
Silva TA, Vasconcelos SML. Blood glucose control as an attenuating factor of oxidative stress in arterial hypertension. Rev Bras Hypertension 2011; 18(3): 113-5.
[63]
Donate-Correa J, Martín-Núñez E, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF. Inflammatory cytokines in diabetic nephropathy. J Diabetes Res 2015; 2015: 948417.
[http://dx.doi.org/10.1155/2015/948417] [PMID: 25785280]
[64]
Peres LA, Matsuo T, Ann HK, et al. Causes of death in chronic renal patients on dialysis. Rev Bras Clin Med 2010; 8(6): 1-5.
[65]
Chakra Ap, Diament J, Forti NA. Classification of dyslipidemias. Rev Soc Cardiol State of São Paulo 2005; 15(6): 465-9.
[66]
Klafke A, Moriguchi E, Barros EJ. Lipid profile of patients with chronic renal failure underconservative treatment, hemodialysis or peritoneal dialysis. J Bras Nefrol 2005; 27(2): 116-23.
[67]
Stosovic M, Stanojevic M, Simic-Ogrizovic S, Jovanovic D, Djukanovic L. The predictive value of anthropometric parameters on mortality in haemodialysis patients. Nephrol Dial Transplant 2011; 26(4): 1367-74.
[http://dx.doi.org/10.1093/ndt/gfq497] [PMID: 20713977]
[68]
Pecoits‐Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter. Nephrol Dial Transplant 2002; 17(11): 28-31.
[69]
Dukkipati R, Kopple JD. Causes and prevention of protein-energy wasting in chronic kidney failure. Semin Nephrol 2009; 29(1): 39-49.
[http://dx.doi.org/10.1016/j.semnephrol.2008.10.006] [PMID: 19121473]
[70]
Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73(4): 391-8.
[http://dx.doi.org/10.1038/sj.ki.5002585] [PMID: 18094682]
[71]
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 2003; 42(5): 864-81.
[http://dx.doi.org/10.1016/j.ajkd.2003.07.016] [PMID: 14582032]
[72]
Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62(6): 2238-45.
[http://dx.doi.org/10.1046/j.1523-1755.2002.00658.x] [PMID: 12427151]
[73]
Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the dialysis outcomes and practice patterns study (dopps): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004; 44(5)(Suppl. 2): 39-46.
[http://dx.doi.org/10.1016/S0272-6386(04)01104-7] [PMID: 15486873]
[74]
Appel GB, Curhan GC, Sheridan AM. Lipid abnormalities in patients with chronic kidney disease not requiring dialysis UpToDate 2014.
[75]
Batista M, Rodrigues CJO. Metabolic changes. J Bras Nefrol 2004; 26(3)(Suppl. 1): 15-9.
[76]
Hariharan D, Vellanki K, Kramer H. The western diet and chronic kidney disease. Curr Hypertens Rep 2015; 17(3): 16.
[http://dx.doi.org/10.1007/s11906-014-0529-6] [PMID: 25754321]
[77]
Kopple JD, Feroze U. The effect of obesity on chronic kidney disease. J Ren Nutr 2011; 21(1): 66-71.
[http://dx.doi.org/10.1053/j.jrn.2010.10.009] [PMID: 21195923]
[78]
Silva Junior GB, Bentes ACSN, Daher EF, Matos SMA. Obesity and kidney disease. J Bras Nefrol 2017; 39(1): 65-9.
[http://dx.doi.org/10.5935/0101-2800.20170011] [PMID: 28355395]
[79]
Declèves AE, Sharma K. Obesity and kidney disease: Differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr Opin Nephrol Hypertens 2015; 24(1): 28-36.
[http://dx.doi.org/10.1097/MNH.0000000000000087] [PMID: 25470014]
[80]
Gupta J, Mitra N, Kanetsky PA, et al. CRIC Study Investigators. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7(12): 1938-46.
[http://dx.doi.org/10.2215/CJN.03500412] [PMID: 23024164]
[81]
Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004; 65(3): 1031-40.
[http://dx.doi.org/10.1111/j.1523-1755.2004.00481.x] [PMID: 14871424]
[82]
Stenvinkel P, Wanner C, Metzger T, et al. Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 2002; 62(5): 1791-8.
[http://dx.doi.org/10.1046/j.1523-1755.2002.00637.x] [PMID: 12371981]
[83]
Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years? Semin Dial 2010; 23(5): 498-509.
[http://dx.doi.org/10.1111/j.1525-139X.2010.00784.x] [PMID: 21039875]
[84]
Jankowska M, Cobo G, Lindholm B, Stenvinkel P. Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol 2017; 191: 58-71.
[http://dx.doi.org/10.1159/000479256] [PMID: 28910791]
[85]
Sun J, Axelsson J, Machowska A, et al. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol 2016; 11(7): 1163-72.
[http://dx.doi.org/10.2215/CJN.10441015] [PMID: 27281698]
[86]
Painter P, Messer-Rehak D, Hanson P, Zimmerman SW, Glass NR. Exercise capacity in hemodialysis, CAPD, and renal transplant patients. Nephron J 1986; 42(1): 47-51.
[http://dx.doi.org/10.1159/000183632] [PMID: 3510400]
[87]
Reboredo MM, Henrique DMN, Bastos MG, Paula RB. Physical exercise in dialyzed patients. Rev Bras Med Sport 2007; 13(6): 427-30.
[http://dx.doi.org/10.1590/S1517-86922007000600014]
[88]
Carvalho CA, Fonseca PCA, Barbosa JB, Machado SP, Santos AM, Silva AAM. Association between cardiovascular risk factors and anthropometric indicators of obesity in university students in São Luís, Maranhão, Brazil. Science Collective Health 2015; 20(2): 479-90.
[89]
Furth SL, Abraham AG, Jerry-Fluker J, et al. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6(9): 2132-40.
[http://dx.doi.org/10.2215/CJN.07100810] [PMID: 21841064]
[90]
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16(7): 2134-40.
[http://dx.doi.org/10.1681/ASN.2005010106] [PMID: 15901764]
[91]
Greffin S, André MB, Matos JPS, et al. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program. J Bras Nefrol 2017; 39(3): 246-52.
[http://dx.doi.org/10.5935/0101-2800.20170040] [PMID: 28902230]
[92]
Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290(13): 697-701.
[http://dx.doi.org/10.1056/NEJM197403282901301] [PMID: 4813742]
[93]
Swaminathan S, Shah SV. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int 2011; 80(5): 453-63.
[http://dx.doi.org/10.1038/ki.2011.178] [PMID: 21697810]
[94]
Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol 2004; 38(5): 405-16.
[http://dx.doi.org/10.1080/00365590410031715] [PMID: 15764253]

Rights & Permissions Print Cite
Article Metrics
12
1
© 2024 Bentham Science Publishers | Privacy Policy